Clinical Trial Update: Safety and Efficacy Extension Study of GreenGene™ F in Previously Treated Patients Diagnosed With Severe Hemophilia A [Phase 3]

View source ↗

Summary

This entry describes a Phase 3 safety and efficacy extension study of GreenGene F in previously treated patients with severe Hemophilia A. The study status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• GreenGene F

Snippet

Sponsor: Green Cross Corporation | Conditions: Hemophilia A | Phase 3 | Status: UNKNOWN